0 Comentários
0 Compartilhamentos
52 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Primary Ciliary Dyskinesia Market is driven by Gene Therapy AdvancementsThe Primary Ciliary Dyskinesia (PCD) Market encompasses diagnostic assays, pharmacological interventions, and innovative gene-based treatments designed to address the structural and functional defects of motile cilia in respiratory epithelium. Products include genetic testing panels, high-resolution microscopy diagnostics, inhaled mucolytics, anti-inflammatory agents, and emerging gene-editing...0 Comentários 0 Compartilhamentos 339 Visualizações 0 Anterior
-
Advanced Therapeutics Market Accelerates with Breakthroughs in Gene and Cell Therapy"Advanced Therapeutics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 The Cutting-Edge Treatment Market is expanding rapidly, driven by increasing consumer demand, technological advancements, and industry-wide innovation. According to top market research firms, businesses in the Innovative Therapeutic Solutions Market are...0 Comentários 0 Compartilhamentos 223 Visualizações 0 Anterior
-
Alpha Thalassemia Market is driven by gene therapy advancementsAlpha thalassemia is a hereditary blood disorder characterized by reduced synthesis of alpha-globin chains, leading to chronic anemia and complications such as splenomegaly and growth retardation. The Alpha Thalassemia Market encompasses a range of products from molecular diagnostics and high-throughput genetic assays to novel therapeutics like gene therapy, transfusion protocols, and iron...0 Comentários 0 Compartilhamentos 14 Visualizações 0 Anterior
-
Alport Syndrome Market Driven by Gene Therapy AdvancesAlport Syndrome Market products primarily include novel gene therapies, diagnostic assays, and supportive renal treatments designed to address the genetic mutations underlying this rare inherited kidney disorder. Gene-editing approaches such as CRISPR/Cas9 and antisense oligonucleotides offer precision correction of COL4A3, COL4A4, and COL4A5 gene defects, delivering targeted intervention that...0 Comentários 0 Compartilhamentos 11 Visualizações 0 Anterior
-
Alport Syndrome Market is Driven by Gene Therapy AdvancesAlport syndrome is a rare progressive renal disease characterized by inherited defects in type IV collagen, leading to hematuria, proteinuria and eventual kidney failure. The Alport Syndrome Market comprises a diverse portfolio of therapeutics, including symptomatic treatments such as ACE inhibitors, emerging small molecules, biologics targeting fibrosis pathways and novel gene therapies...0 Comentários 0 Compartilhamentos 246 Visualizações 0 Anterior
-
Gene Therapy in Ophthalmology Market is Driven by Innovative Treatment TechnologiesGene therapy in ophthalmology involves the use of viral and non-viral vectors to deliver genetic material directly into ocular tissues, aiming to treat inherited retinal diseases, age-related macular degeneration (AMD), and other degenerative disorders of the eye. Key products include adeno-associated virus (AAV) vectors, lentiviral systems, and emerging CRISPR/Cas-based modalities, each...0 Comentários 0 Compartilhamentos 102 Visualizações 0 Anterior
-
Gene Therapy Market Innovation, Size, Share, Growth and Trend Analysis By 2032The Gene Therapy Market is entering a transformative phase, with forecasts predicting strong growth and groundbreaking innovations by 2032. Driven by rising demand, digital adoption, and evolving consumer needs, the industry is rapidly expanding across global markets. A recent report highlights key drivers such as increasing market share, advanced segmentation, and the growing...0 Comentários 0 Compartilhamentos 61 Visualizações 0 Anterior
-
Giant Axonal Neuropathy (GAN) Market is driven by Gene Therapy AdvancementsGiant Axonal Neuropathy (GAN) is a rare, inherited neurodegenerative disorder characterized by progressive nerve damage due to mutations in the GAN gene, leading to impaired intracellular transport within neurons. GAN market offerings primarily comprise gene replacement therapies, viral vectors, and small-molecule modulators designed to correct or compensate for the defective gigaxonin protein....0 Comentários 0 Compartilhamentos 309 Visualizações 0 Anterior
-
Haemophilia Gene Therapy Market Size, Growth & Industry ShareHere's a comprehensive overview of the Hemophilia Gene Therapy Market as of 2025, encompassing recent developments, market drivers, restraints, regional segmentation, emerging trends, top use cases, major challenges, and attractive opportunities. The global haemophilia gene therapy market is expected to grow from USD 350 million in 2022 to USD 5165.26 million by 2030, at a...0 Comentários 0 Compartilhamentos 231 Visualizações 0 Anterior
-
Lamellar Ichthyosis Market is driven by Advancements in Gene TherapyThe Lamellar Ichthyosis Market encompasses a range of therapeutic products designed to manage a rare genetic skin disorder characterized by thickened, scaly skin and impaired barrier function. Current offerings include topical emollients and keratolytics, systemic retinoids, biologics, and emerging gene therapy candidates aimed at correcting the underlying genetic mutation. Advantages of these...0 Comentários 0 Compartilhamentos 154 Visualizações 0 Anterior
-
Non-Viral Transfection Reagents Market is driven by Gene Therapy DemandThe Non-Viral Transfection Reagents Market encompasses a variety of delivery systems—including lipid-based formulations, polymer-based carriers, peptides, and inorganic nanoparticles—designed to transport nucleic acids, siRNA, mRNA, and CRISPR components into mammalian cells. These reagents offer significant advantages over viral vectors, including reduced immunogenicity, easier...0 Comentários 0 Compartilhamentos 145 Visualizações 0 Anterior
-
Genomics Market CAGR: Growth, Share, Value, Insights, and Trends"Global Genomics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: The global Genomics market was valued at USD 42.73 billion in 2024 and is expected to reach USD 143.73 billion by 2032 Genomics Market Set to Revolutionize Global Industries with Rapid Growth and Innovation The Genomics Market is emerging as a...0 Comentários 0 Compartilhamentos 107 Visualizações 0 Anterior
-
Genomics Market Companies: Growth, Share, Value, Analysis, and Trends"Genomics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 The DNA Sequencing Market is undergoing significant transformation, driven by technological advancements, shifting consumer preferences, and increasing industry investments. According to top market research companies, the Genetic Research Market is witnessing rapid growth as...0 Comentários 0 Compartilhamentos 262 Visualizações 0 Anterior
-
Genomics Market Research Report: Growth, Share, Value, Trends, and Insights"Global Genomics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: The global Genomics market was valued at USD 42.73 billion in 2024 and is expected to reach USD 143.73 billion by 2032 Genomics Market Poised for Robust Growth Amidst Dynamic Industry Trends The Genomics Market is experiencing unprecedented...0 Comentários 0 Compartilhamentos 114 Visualizações 0 Anterior
-
Genomics Market Insights: Growth, Share, Value, Size, and Analysis"Genomics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 The DNA Sequencing Market is undergoing significant transformation, driven by technological advancements, shifting consumer preferences, and increasing industry investments. According to top market research companies, the Genetic Research Market is witnessing rapid growth as...0 Comentários 0 Compartilhamentos 129 Visualizações 0 Anterior
-
Asia-Pacific Biologics Market Revenue Forecast: Growth, Share, Value, and Trends"Asia-Pacific Biologics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2030 The APAC Biopharmaceuticals Market is witnessing strong growth across multiple sectors, including [industry name], where demand is rising due to innovation and market expansion. Market research data indicates that businesses in the Biotechnology Drug Industry are...0 Comentários 0 Compartilhamentos 292 Visualizações 0 Anterior
-
Axicabtagene Ciloleucel Market to Witness Strong Growth Driven by Advances in CAR T-cell Therapies"Global Axicabtagene Ciloleucel Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: The global axicabtagene ciloleucel market size was valued at USD 3.20 billion in 2024 and is projected to reach USD 9.81 billion by 2032, with a CAGR of 15.02% during the forecast period of 2025 to 2032. Axicabtagene Ciloleucel Market Set...0 Comentários 0 Compartilhamentos 66 Visualizações 0 Anterior
-
Bioassay Services Market is driven by rising R&D investmentsThe Bioassay Services Market encompasses a broad range of laboratory testing and analytical solutions designed to evaluate the biological activity, safety, and potency of pharmaceuticals, biotechnology products, and novel compounds. Service offerings include in vitro assays, cell-based screens, high-throughput screening, potency testing, immunoassays, and assay development, which collectively...0 Comentários 0 Compartilhamentos 272 Visualizações 0 Anterior
-
Genomic Medicine Market Growth, Share, Value, Size, Analysis, Scope, Demand"Genomic Medicine Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 The Precision Medicine Market is witnessing significant growth, driven by evolving consumer demands, technological advancements, and expanding global trade. Leading market research companies indicate that the DNA-Based Therapy Market is expected to experience steady expansion in...0 Comentários 0 Compartilhamentos 190 Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek